Drug delivery strategy plays a major role within the future potential success of your product. Whether nurturing a new compound or developing a line of generic products, choosing the most effective delivery strategy can open the door to both opportunities, and hurdles.
With an increasing diversity of compounds addressing more drug targets, the available range and sophistication of delivery technologies has expanded with the goal of increasing the successful rate of new chemical entities.
One industry leader and expert assisting drug product development organizations advance in this space is Adare Pharmaceuticals.
Adare Pharmaceuticals is a global technology driven specialty CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s proprietary technology platforms specialize in ODT’s, taste masking and customized drug release.
With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by partners in more than 100 countries globally.
Check out the innovative drug development technology platforms Adare Pharmaceuticals offers:
2024 Controlled & Modified Drug Release Summit
(May 14-15, 2024, Princeton, NJ)